Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study

Autor: Vicente Artola Arita, Martijn E Van De Lande, Neda Khalilian Ekrami, Bao-Oanh Nguyen, Joost M Van Melle, Bastiaan Geelhoed, Ruben R De With, Vanessa Weberndörfer, Ömer Erküner, Hans Hillege, Dominik Linz, Hugo Ten Cate, Henri M H Spronk, Tim Koldenhof, Robert G Tieleman, Ulrich Schotten, Harry J G M Crijns, Isabelle C Van Gelder, Michiel Rienstra

Publikováno v: Europace, 25(4), 1323-1331. Oxford University Press
Arita, V A, Van de Lande, M E, Ekrami, N K, Nguyen, B-O, Van Melle, J M, Geelhoed, B, De With, R R, Weberndorfer, V, Erkuner, O, Hillege, H, Linz, D, Ten Cate, H, Spronk, H M H, Koldenhof, T, Tieleman, R G, Schotten, U, Crijns, H J G M, Van Gelder, I C & Rienstra, M 2023, ' Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation : data from the RACE V study ', Europace, vol. 25, no. 4, pp. 1323–1331 . https://doi.org/10.1093/europace/euac268

Aims The recent 4S-AF (scheme proposed by the 2020 ESC AF guidelines to address stroke risk, symptom severity, severity of AF burden and substrate of AF to provide a structured phenotyping of AF patients in clinical practice to guide therapy and asse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e789f623bce6e1674add2a8167841c5a
https://research.rug.nl/en/publications/dc1bca07-da76-46d9-9744-816b388cec86